Posted by ABMN Staff on May 4th, 2024
GSK (LON:GSK – Get Free Report) had its price target lifted by equities research analysts at JPMorgan Chase & Co. from GBX 1,530 ($19.22) to GBX 1,660 ($20.85) in a report issued on Thursday, Marketbeat.com reports. The...
More of this article »